Beyond Glucocorticoids for IgG4-Related Disease

被引:0
作者
Spiera, Robert [1 ,2 ]
机构
[1] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA
[2] Hosp Special Surg, Dept Med, Scleroderma Vasculitis & Myositis Ctr, New York, NY 10021 USA
关键词
MANAGEMENT; STATEMENT;
D O I
10.1056/NEJMe2413286
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1232 / 1233
页数:2
相关论文
共 9 条
  • [1] Rituximab for IgG4-related disease: a prospective, open-label trial
    Carruthers, Mollie N.
    Topazian, Mark D.
    Khosroshahi, Arezou
    Witzig, Thomas E.
    Wallace, Zachary S.
    Hart, Philip A.
    Deshpande, Vikram
    Smyrk, Thomas C.
    Chari, Suresh
    Stone, John H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) : 1171 - 1177
  • [2] 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Chung, Sharon A.
    Langford, Carol A.
    Maz, Mehrdad
    Abril, Andy
    Gorelik, Mark
    Guyatt, Gordon
    Archer, Amy M.
    Conn, Doyt L.
    Full, Kathy A.
    Grayson, Peter C.
    Ibarra, Maria F.
    Imundo, Lisa F.
    Kim, Susan
    Merkel, Peter A.
    Rhee, Rennie L.
    Seo, Philip
    Stone, John H.
    Sule, Sangeeta
    Sundel, Robert P.
    Vitobaldi, Omar, I
    Warner, Ann
    Byram, Kevin
    Dua, Anisha B.
    Husainat, Nedaa
    James, Karen E.
    Kalot, Mohamad A.
    Lin, Yih Chang
    Springer, Jason M.
    Turgunbaev, Marat
    Villa-Forte, Alexandra
    Turner, Amy S.
    Mustafa, Reem A.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 (08) : 1366 - 1383
  • [3] Consensus statement on the pathology of IgG4-related disease
    Deshpande, Vikram
    Zen, Yoh
    Chan, John K.
    Yi, Eunhee E.
    Sato, Yasuharu
    Yoshino, Tadashi
    Kloeppel, Guenter
    Heathcote, J. Godfrey
    Khosroshahi, Arezou
    Ferry, Judith A.
    Aalberse, Rob C.
    Bloch, Donald B.
    Brugge, William R.
    Bateman, Adrian C.
    Carruthers, Mollie N.
    Chari, Suresh T.
    Cheuk, Wah
    Cornell, Lynn D.
    Fernandez-Del Castillo, Carlos
    Forcione, David G.
    Hamilos, Daniel L.
    Kamisawa, Terumi
    Kasashima, Satomi
    Kawa, Shigeyuki
    Kawano, Mitsuhiro
    Lauwers, Gregory Y.
    Masaki, Yasufumi
    Nakanuma, Yasuni
    Notohara, Kenji
    Okazaki, Kazuich
    Ryu, Ji Kon
    Saeki, Takako
    Sahani, Dushyant V.
    Smyrk, Thomas C.
    Stone, James R.
    Takahira, Masayuki
    Webster, George J.
    Yamamoto, Motohisa
    Zamboni, Giuseppe
    Umehara, Hisanori
    Stone, John H.
    [J]. MODERN PATHOLOGY, 2012, 25 (09) : 1181 - 1192
  • [4] Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients
    Ebbo, Mikael
    Grados, Aurelie
    Samson, Maxime
    Groh, Matthieu
    Loundou, Anderson
    Rigolet, Aude
    Terrier, Benjamin
    Guillaud, Constance
    Carra-Dalliere, Clarisse
    Renou, Frederic
    Pozdzik, Agnieszka
    Labauge, Pierre
    Palat, Sylvain
    Berthelot, Jean-Marie
    Pennaforte, Jean-Loup
    Wynckel, Alain
    Lebas, Celine
    Le Gouellec, Noemie
    Quemeneur, Thomas
    Dahan, Karine
    Carbonnel, Franck
    Leroux, Gaelle
    Perlat, Antoinette
    Mathian, Alexis
    Cacoub, Patrice
    Hachulla, Eric
    Costedoat-Chalumeau, Nathalie
    Harle, Jean-Robert
    Schleinitz, Nicolas
    [J]. PLOS ONE, 2017, 12 (09):
  • [5] International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease
    Khosroshahi, A.
    Wallace, Z. S.
    Crowe, J. L.
    Akamizu, T.
    Azumi, A.
    Carruthers, M. N.
    Chari, S. T.
    Della-Torre, E.
    Frulloni, L.
    Goto, H.
    Hart, P. A.
    Kamisawa, T.
    Kawa, S.
    Kawano, M.
    Kim, M. H.
    Kodama, Y.
    Kubota, K.
    Lerch, M. M.
    Lohr, M.
    Masaki, Y.
    Matsui, S.
    Mimori, T.
    Nakamura, S.
    Nakazawa, T.
    Ohara, H.
    Okazaki, K.
    Ryu, J. H.
    Saeki, T.
    Schleinitz, N.
    Shimatsu, A.
    Shimosegawa, T.
    Takahashi, H.
    Takahira, M.
    Tanaka, A.
    Topazian, M.
    Umehara, H.
    Webster, G. J.
    Witzig, T. E.
    Yamamoto, M.
    Zhang, W.
    Chiba, T.
    Stone, J. H.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67 (07) : 1688 - 1699
  • [6] De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease
    Mattoo, Hamid
    Mahajan, Vinay S.
    Della-Torre, Emanuel
    Sekigami, Yurie
    Carruthers, Mollie
    Wallace, Zachary S.
    Deshpande, Vikram
    Stone, John H.
    Pillai, Shiv
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 134 (03) : 679 - 687
  • [7] CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up
    Mueller, Fabian
    Taubmann, Jule
    Bucci, Laura
    Wilhelm, Artur
    Bergmann, Christina
    Voelkl, Simon
    Aigner, Michael
    Rothe, Tobias
    Minopoulou, Ioanna
    Tur, Carlo
    Knitza, Johannes
    Kharboutli, Soraya
    Kretschmann, Sascha
    Vasova, Ingrid
    Spoerl, Silvia
    Reimann, Hannah
    Munoz, Luis
    Gerlach, Roman G.
    Schaefer, Simon
    Grieshaber-Bouyer, Ricardo
    Korganow, Anne-Sophie
    Farge-Bancel, Dominique
    Mougiakakos, Dimitrios
    Bozec, Aline
    Winkler, Thomas
    Kroenke, Gerhard
    Mackensen, Andreas
    Schett, Georg
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (08) : 687 - 700
  • [8] Inebilizumab for Treatment of IgG4-Related Disease
    Stone, John H.
    Khosroshahi, Arezou
    Zhang, Wen
    Della Torre, Emanuel
    Okazaki, Kazuichi
    Tanaka, Yoshiya
    Loehr, J. Matthias
    Schleinitz, Nicolas
    Dong, Lingli
    Umehara, Hisanori
    Lanzillotta, Marco
    Wallace, Zachary S.
    Ebbo, Mikael
    Webster, George J.
    Valle, Fernando Martinez
    Nayar, Manu K.
    Perugino, Cory A.
    Rebours, Vinciane
    Dong, Xinxin
    Wu, Yanping
    Li, Qing
    Rampal, Nishi
    Cimbora, Daniel
    Culver, Emma L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2024,
  • [9] Current and future advances in practice: IgG4-related disease
    Wallace, Zachary S.
    Katz, Guy
    Hernandez-Barco, Yasmin G.
    Baker, Matthew C.
    [J]. RHEUMATOLOGY ADVANCES IN PRACTICE, 2024, 8 (02)